Analysis of Drug Use in a Patient with Brucellosis Combined with Liver Dysfunction by Clinical Pharmacists
- VernacularTitle:临床药师对1例布鲁氏菌病合并肝功能异常患者的用药分析
- Author:
Xueyan YIN
1
;
Jing LI
2
;
Yongjun ZHANG
3
Author Information
1. College of Pharmacy，Shihezi University，Xinjiang Shihezi 832000，China
2. Dept. of Pharmacy，the First Affiliated Hospital of Medical College of Shihezi University，Xinjiang Shihezi 832000，China
3. Dept. of Clinical Education，the First Affiliated Hospital of Medical College of Shihezi University，Xinjiang Shihezi 832000，China
- Publication Type:Journal Article
- Keywords:
Brucellosis;
Liver dysfunction;
Clinical pharmacist;
Rational drug use
- From:
China Pharmacy
2020;31(5):632-636
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE：To provide reference for the selection of drug treatment plan in patients with Brucellosis combined with liver dysfunction. METHODS ：Clinical pharmacists analyzed drug treatment plan in a patient with Brucellosis combined with liver dysfunction in the First Affiliated Hospital of Medical College of Shihezi University. Referring to Brucella treatment guideline . Consensus statement by the American association of clini - HbA1c cal endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management al - and domestic and foreign clinical information ，the suggesti ons were put forward according to the change of liver dysfunction. RESULTS：The patient had chronic infection and moderate liver injury. The liver dysfunction in this patient was a common complication of Brucellosis. After consultation of doctors and pharmacists ，in consideration of the abnormal liver function ， intravenous drip of levofloxacin （0.5 g，qd）was given in the patient for anti-infection treatment. After the liver function was improved，levofloxacin was stopped ，and intravenous drip of rifampin （0.6 g，qd）and oral administration of doxycycline （100 mg，bid）were given for anti-infection treatment instead ；during the treatment period ，intravenous drip of reduced glutathione （1.8 g，qd）and diammonium glycyrrhizinate （150 mg，qd）were given for anti-inflammatory and liver protecting treatment. During the treatment，the clinical pharmacists closely monitored ADR of patients ，and carried out medication education for patients to improve the compliance. 10 d after medication ，although some of the liver function indexes of the patient did not return to normal ，but Brucellosis and liver dysfunction symptoms were improved. The patient could continue to take the same dose of rifampin and doxycycline after discharge. CONCLUSIONS ：When the patients with Brucellosis have abnormal liver function ，anti-infection treatment should be the main treatment target. The clinical pharmacists should refer to the relevant guidelines and combine with the clinical practice to help doctors adjust the treatment plan ，so as to ensure the safety and effectiveness of the patients ’medication.
